Received Apr 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Havrix was administered after a temperature excursion to one patient; This non-serious case was reported by a nurse via other manufacturer and described the occurrence of incorrect storage of drug in a patient who received HAV (Havrix) for prophylaxis. On an unknown date, the patient received Havrix. On an unknown date, an unknown time after receiving Havrix, the patient experienced incorrect storage of drug (Verbatim: Havrix was administered after a temperature excursion to one patient). The outcome of the incorrect storage of drug was not applicable. Additional Information: GSK Receipt Date: 16-APR-2025 Nurse practitioner reported Havrix was administered after a temperature excursion to one patient, which led to Incorrect storage of drug. Nurse practitioner did not provide patient information or date of administration at the time of the call. No further information provided. No additional adverse event reported.